Daniel P. Getman

1.6k citations

31 papers · 1.4k indexed · h-index 20

Virology top 5%
- HIV Research and Treatment 5
Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis 8
- Click Chemistry and Applications 4
Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 7
Process Chemistry and Technology top 10%
Molecular Biology top 10%
- Chemical Synthesis and Analysis 8
- Protein Kinase Regulation and GTPase Signaling 6
Oncology
- Peptidase Inhibition and Analysis 9
Cancer Research
- Protease and Inhibitor Mechanisms 4

Co-authors: Stanley L. Hazen Randy H. Weiss Richard W. Gross Charles A. McWherter Jeffrey I. Gordon Gary DeCrescenzo R. Heintz Martin L. Bryant
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Biological Chemistry (3 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Daniel P. Getman

31 papers receiving 1.3k citations

Peers

Countries citing papers authored by Daniel P. Getman

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Getman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Getman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Getman more than expected).

Fields of papers citing papers by Daniel P. Getman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Getman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Getman. The network helps show where Daniel P. Getman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel P. Getman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel P. Getman Line = papers co-authored together Daniel P. Getman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synthesis and Structure−Activity Relationships of β- and α-Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors with Oral Antitumor Efficacy Journal of Medicinal Chemistry ·Daniel P. Becker,Clara I. Villamil,Thomas E. Barta,Louis J. Bedell,Terri L. Boehm,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,R. Heintz,Susan C. Howard,Sprenger M. A. Peter,Joseph J. McDonald,В. Д. Щербаков,Bao-jun,Pramod P. Mehta,Grace E. Munie,Craig Swearingen	2005	51
2	Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease Bioorganic & Medicinal Chemistry ·Srinivasan Nagarajan,Jupenris Sidauruk,Daniel P. Getman,Zhao Xu,James A. Sikorski,Jeffrey L Walker,Joseph J. McDonald,Kathryn Houseman,Kikuchi Yuji,Nandini Kishore,Pramod P. Mehta,C Phillips,Elizabeth A. Wedemeyer	2003	80
3	α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1 Bioorganic & Medicinal Chemistry Letters ·Daniel P. Becker,Thomas E. Barta,Louis J. Bedell,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,Amiribakhtiar Hassan,Pramod P. Mehta,L. Yılmazoğlu,Grace E. Munie,Craig Swearingen,Clara I. Villamil	2001	27
4	α-Alkyl-α-amino-β-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1 Bioorganic & Medicinal Chemistry Letters ·Daniel P. Becker,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,Amiribakhtiar Hassan,Pramod P. Mehta,Grace E. Munie,Craig Swearingen	2001	19
5	Discovery of a novel series of selective MMP inhibitors: Identification of the γ-sulfone-thiols Bioorganic & Medicinal Chemistry Letters ·John N. Freskos,L. Yılmazoğlu,Gary DeCrescenzo,R. Heintz,Daniel P. Getman,Susan C. Howard,Nandini Kishore,Joseph J. McDonald,Grace E. Munie,Shaukat H. Rangwala,Craig Swearingen,Charles F. Voliva,Dean J. Welsch	1999	21
6	Scanning Alanine Mutagenesis and De-peptidization of a Candida albicans Myristoyl-CoA:ProteinN-Myristoyltransferase Octapeptide Substrate Reveals Three Elements Critical for Molecular Recognition Journal of Biological Chemistry ·Charles A. McWherter,Warren J. Rocque,Mark E. Zupec,Sandra K. Freeman,David Brown,Balekudru Devadas,Daniel P. Getman,James A. Sikorski,Jeffrey I. Gordon	1997	29
7	Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: Protein N-myristoyltransferase: A new approach to antifungal therapy Biopolymers ·James A. Sikorski,Balekudru Devadas,Mark E. Zupec,Sandra K. Freeman,David Brown,Abdullah,Srinivasan Nagarajan,Pramod P. Mehta,Wu Qinglei,Nandini S. Kishore,Martin L. Bryant,Daniel P. Getman,Charles A. McWherter,Jeffrey I. Gordon	1997	46
8	Design and Syntheses of Potent and Selective Dipeptide Inhibitors of Candida albicans Myristoyl-CoA:Protein N-Myristoyltransferase Journal of Medicinal Chemistry ·Balekudru Devadas,Mark E. Zupec,Sandra K. Freeman,David Brown,Srinivasan Nagarajan,James A. Sikorski,Charles A. McWherter,Daniel P. Getman,Jeffrey I. Gordon	1995	53
9	Inhibitors of HIV-1 Protease Containing the Novel and Potent (R)-(Hydroxyethyl)sulfonamide Isostere Journal of Medicinal Chemistry ·Michael L. Vazquez,Martin L. Bryant,Michael Clare,Gary DeCrescenzo,Elizabeth M. Doherty,John N. Freskos,Daniel P. Getman,Kathryn Houseman,K.I. Adamou,Kikuchi Yuji,Richard A. Mueller,Huey‐Sheng Shieh,William C. Stallings,Roderick A. Stegeman,D. E. Loupe	1995	37
10	HIV‐1 Protease inhibitors: Their development, mechanism of action and clinical potential Reviews in Medical Virology ·Deenan Pillay,Martin L. Bryant,Daniel P. Getman,Douglas D. Richman	1995	22
11	Nucleophilic Opening ofN-Carboalkoxy-2,3-anhydro-1-deoxymannojirimycin. A Useful Method for the Syntheses of 2-, 3- and 2,3-Disubstituted 1-Deoxynojirimycin Analogs Journal of Carbohydrate Chemistry ·Ish Khanna,Francis J. Koszyk,Kimberly Martinod,Richard M. Weier,Ahmed Omar Shami,Richard A. Mueller,Shashidhar N. Rao,V. Pravdić,Daniel P. Getman,Gary DeCrescenzo,R. Heintz	1995	11
12	SC-52151, a novel inhibitor of the human immunodeficiency virus protease Antimicrobial Agents and Chemotherapy ·Martin L. Bryant,Daniel P. Getman,Hadibandhu Pattanayak,J. Joseph Marr,Michael Clare,Foster Darwin Jaya Buulolo,David M. Lansky,Gary DeCrescenzo,R. Heintz,Muhammed Emin Aksu	1995	27
13	Structural determinants of haloenol lactone-mediated suicide inhibition of canine myocardial calcium-independent phospholipase A2 Journal of Medicinal Chemistry ·Matías Garavaglia,Randy H. Weiss,Stanley L. Hazen,Etih Henriyani,Karl Aston,Patrick J. Lennon,Daniel P. Getman,Richard W. Gross	1993	60
14	Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere Journal of Medicinal Chemistry ·Daniel P. Getman,Gary DeCrescenzo,R. Heintz,K L Reed,John J. Talley,Martin L. Bryant,Michael Clare,Kathryn Houseman,J. Joseph Marr	1993	153
15	ChemInform Abstract: A Convenient Asymmetric Synthesis of the Unnatural Amino Acid 2,6‐ Dimethyl‐L‐tyrosine. ChemInform ·John H. Dygos,Wei Guo Li,Dini Safira,Okringbo,Daniel P. Getman,Roy A. Periana,Gerhard Beck	1992	1
16	Influence of polyfluorination of the phenylalanine ring of angiotensin II on conformation and biological activity Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Philippe R. Bovy,Daniel P. Getman,John Matsoukas,Graham J. Moore	1991	13
17	Selective functionalization of the C2 hydroxyl group of N-carbobenzyloxy-4,6--benzylidene-1-deoxynojirimycin Tetrahedron Letters ·Daniel P. Getman,Gary DeCrescenzo,R. Heintz	1991	11
18	Photochemical transformations of small ring compounds. 95. The problem of regioselectivity in the photochemical ring-opening reaction of 3-phenyl- and 3-vinyl-substituted cyclopropenes to indenes and 1,3-cyclopentadienes The Journal of Organic Chemistry ·Albert Padwa,Thomas J. Blacklock,Daniel P. Getman,Д. А. Тимушев,Jayanthi Narayanaswamy	1978	43
19	Photochemical transformations of small ring compounds. 86. Regioselectivity of bond cleavage in the photochemical rearrangement of 3-vinylcyclopropenes Journal of the American Chemical Society ·Albert Padwa,Thomas J. Blacklock,Daniel P. Getman,Д. А. Тимушев	1977	16
20	On the mechanism of the photochemical rearrangement of 3-phenyl substituted cyclopropenes to indenes Tetrahedron Letters ·Albert Padwa,Jayanthi Narayanaswamy,Daniel P. Getman	1977	5

About Daniel P. Getman

Daniel P. Getman is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 31 papers that have together received 1.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (9 papers), Chemical Synthesis and Analysis (8 papers), Carbohydrate Chemistry and Synthesis (8 papers), HIV/AIDS drug development and treatment (7 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), HIV Research and Treatment (5 papers), Click Chemistry and Applications (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Virology (127 citations), Organic Chemistry (451 citations) and Infectious Diseases (225 citations). Daniel P. Getman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Stanley L. Hazen, Randy H. Weiss, Richard W. Gross, Charles A. McWherter, Jeffrey I. Gordon, Gary DeCrescenzo, R. Heintz, Martin L. Bryant, James A. Sikorski and Patrick J. Lennon. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Tetrahedron Letters and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact